Search

Search results

172 results found

Alison Krustapentus, FNP-BC

Person: Nurse Practitioner, Gastroenterology

Alison Krustapentus, NP is a Family Nurse Practitioner in the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center. She earned her bachelor’s degree from Boston College and her Master of Science in Nursing from the MGH Institute of Health Professions. With nearly a decade of...

Alan C. Moss, M.D.

Person: Professor, Boston University Chobanian & Avedisian School of Medicine, Director, Crohn's & Colitis Program, Boston Medical Center

Alan Moss, MD, FACG, AGAF, FEBG, FRCPI is a clinician-scientist with an interest in Crohn's disease and Ulcerative Colitis (Inflammatory Bowel Disease, IBD). His clinical expertise is in management of IBD, and he is Director of the Crohn's & Colitis Program at Boston Medical Center. His research...

Conor Lahiff, M.D.

Person: Consultant Gastroenterologist, Mater Misericordiae Hospital

Dr. Conor Lahiff is a Consultant Gastroenterologist with expertise in inflammatory bowel disease (IBD) and advanced endoscopy, as well as general gastroenterology. Originally from Dublin, he studied medicine at University College Dublin and then completed higher specialist training in...

A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice.

Publication: Journal Article

Salwen-Deremer, Jessica K, Sarah Ballou, Megan Petrik, Miguel Regueiro, Corey A Siegel, Laurie Keefer, and GastroPsych Business Plan Working Group. 2025. “A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice.”. Gastroenterology.

Impact of Estrogen on Purinergic Signaling in Microvascular Disease.

Publication: Journal Article

Cassavaugh, Jessica, Maria Serena Longhi, and Simon C Robson. 2025. “Impact of Estrogen on Purinergic Signaling in Microvascular Disease.”. International Journal of Molecular Sciences 26 (5).

Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.

Publication: Journal Article

Owings, Anna H, Sarah C Glover, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 70 (3): 1248-49.

Retraction notice to "Screening for novel central nervous system biomarkers in veterans with Gulf War Illness" [Neurotoxicology and Teratology 61 (2017) 36-46].

Publication: Journal Article

Abou-Donia, Mohamed B, Lisa A Conboy, Efi Kokkotou, Eric Jacobson, Eman M Elmasry, Passent Elkafrawy, Megan Neely, Cameron R Dale Bass, and Kimberly Sullivan. 2025. “Retraction Notice to ‘Screening for Novel Central Nervous System Biomarkers in Veterans With Gulf War Illness’ [Neurotoxicology and Teratology 61 (2017) 36-46].”. Neurotoxicology and Teratology 107: 107423.

Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?

Publication: Journal Article

Papamichael, Konstantinos, and Adam S Cheifetz. 2025. “Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?”. Alimentary Pharmacology & Therapeutics 61 (2): 369-70.

Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.

Publication: Journal Article

Burdine, Lauren K, Shana Rakowsky, Laurie Grossberg, Loren Rabinowitz, BIDMC IBD Research Center, Adam S Cheifetz, and Sarah Ballou. 2024. “Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.”. Gastro Hep Advances 3 (8): 1135-37.

Adenosine-mediated immune responses in inflammatory bowel disease.

Publication: Journal Article

Vuerich, Marta, Du Hanh Nguyen, Davide Ferrari, and Maria Serena Longhi. 2024. “Adenosine-Mediated Immune Responses in Inflammatory Bowel Disease.”. Frontiers in Cell and Developmental Biology 12: 1429736.